STOCKWATCH
·
Pharmaceuticals
Quarterly Result12 May 2026, 02:43 pm

Novartis India FY26: Revenue from Operations at ₹2,105.8 Mn

AI Summary

Novartis India Ltd announced its audited financial results for the quarter and financial year ended March 31, 2026. Key highlights include revenue from operations of ₹2,105.8 million for the year ended March 31, 2026, compared to ₹1,990.7 million in the previous year. The company reported a profit for the year of ₹931.8 million, compared to ₹1,009.0 million in the previous year. The Board also addressed disclosures related to loans, debt securities, and related party transactions.

Key Highlights

  • Revenue from Operations for FY26 reached ₹2,105.8 million.
  • Profit for the year stood at ₹931.8 million.
  • Total Comprehensive Income for the year was ₹946.0 million.
  • The company declared no outstanding defaults on loans or debt securities.
  • Related Party Transactions are disclosed in Annexure III.
NOVARTIND
Pharmaceuticals
NOVARTIS INDIA LTD.

Price Impact